Malin Corporation PLC (MLC)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell
€7.70
Buy
€9.80
€-0.10 (-1.28%)
Prices updated at 10 Dec 2025, 14:05 GMT
| Prices minimum 15 mins delay
Prices in EUR
Malin Corporation PLC is a global life sciences company. The firm's investee companies are in science and discovery, clinical and commercial sectors.
-0.53%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| - | - | |
| - | - | |
| -4m | -2m | |
| - | - | |
| - | - | |
| 400,000 | 300,000 | |
| Sales, General and administrative | 3m | 2m |
| Interest expenses | 200,000 | 200,000 |
| Provision for income taxes | - | - |
| Operating expenses | 4m | 3m |
| Income before taxes | - | - |
| Net income available to common shareholders | - | - |
| - | - | |
| Net interest income | 1m | 1m |
| Advertising and promotion | - | - |
| Net investment income, net | -100,000 | 100,000 |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | - | - |
| Free cash flow per share | -0.1667 | -0.1372 |
| Book value/share | 5.0933 | 6.2305 |
| Debt equity ratio | - | - |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 36m | 63m |
| Current liabilities | 1m | 1m |
| Total capital | 110m | 193m |
| Total debt | 100,000 | - |
| Total equity | 110m | 193m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 117m | 199m |
| Total liabilities | - | - |
| Cash and cash equivalents | 29m | 62m |
| Common stock | 19m | 19m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 174m | 29m |
| Cash dividends paid | - | - |
| -3m | -1m | |
| Investments (gains) losses | 400,000 | 34m |
| 29m | 62m | |
| Net income | - | - |
| -3m | -1m | |
| - | - |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
